1887

Abstract

Data from 4727 invasive isolates of submitted to the Scottish Haemophilus, Legionella, Meningococcus and Pneumococcus Reference Laboratory between 1999 and 2007 were analysed to establish susceptibility profiles to penicillin, erythromycin and cefotaxime. Pneumococcal resistance to penicillin over the study period remained low, with only 0.2 % (=7/4727) of isolates falling into this category (MIC ≥2 mg l). These isolates have been sporadic, and have mainly represented serogroup 14 (ST9) and 9 (ST156). In comparison, the ‘intermediate sensitivity’ group (MIC 0.12–1 mg l) ranged between 2 and 6 % per year, the majority from serogroup 9 (ST156). Over the study period, we found that 12 % (=585/4727) of isolates were erythromycin-resistant (MIC >0.5 mg l), with the majority (=467; 80 %) of these isolates identified as serogroup 14 (ST9). Cephalosporin resistance (cefotaxime MIC >1 mg l) was found in only 0.06 % (=2/3135) of isolates. Internationally recognized clones (Pneumococcal Molecular Epidemiology Network) accounted for 35 % (=28/81) of the penicillin non-susceptible isolates and 75 % (=248/330) of the macrolide-resistant isolates, with ST9 and ST306 predominating. Between 1999 and 2007 we found that 11.6 % (=18/155) of the penicillin non-susceptible isolates and 4.8 % (=28/585) of the macrolide-resistant isolates were from serogroups not covered by the 7-valent conjugate pneumococcal vaccine in use in the UK since 2006. Susceptibility to first-line antimicrobial agents for invasive pneumococcal disease in Scotland remained high over the period 1999–2007.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.022954-0
2010-10-01
2019-10-22
Loading full text...

Full text loading...

/deliver/fulltext/jmm/59/10/1212.html?itemId=/content/journal/jmm/10.1099/jmm.0.022954-0&mimeType=html&fmt=ahah

References

  1. Ardanuy, C., Tubau, F., Pallares, R, Calatayud, L., Domínguez, M. A., Rolo, D., Grau, I., Martín, R., Liñares, J. & other authors ( 2009; ). Epidemiology of invasive pneumococcal disease among adult patients in Barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997–2007. Clin Infect Dis 48, 57–64.[CrossRef]
    [Google Scholar]
  2. Biedenbach, D. J., Moet, G. J. & Jones, R. N. ( 2004; ). Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997–2002). Diagn Microbiol Infect Dis 50, 59–69.[CrossRef]
    [Google Scholar]
  3. Brueggemann, A. B. & Spratt, B. G. ( 2003; ). Geographic distribution and clonal diversity of Streptococcus pneumoniae serotype 1 isolates. J Clin Microbiol 41, 4966–4970.[CrossRef]
    [Google Scholar]
  4. BSAC ( 2008; ). BSAC Methods for Antimicrobial Susceptibility Testing, Version 7.1, February 2008. British Society for Antimicrobial Chemotherapy.
  5. Chaudhuri, A., Martin, P. M., Kennedy, P. G. E., Andrew Seaton, R., Portegies, P., Bojar, M. & Steiner, I., EFNS Task Force ( 2008; ). EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol 15, 649–659.[CrossRef]
    [Google Scholar]
  6. Choi, E. H. & Lee, H. J. ( 1998; ). Clinical outcome of invasive infections by penicillin-resistant Streptococcus pneumoniae in Korean children. Clin Infect Dis 26, 1346–1354.[CrossRef]
    [Google Scholar]
  7. CLSI ( 2008; ). MIC interpretive standards for Streptococcus pneumoniae. Performance Standards for Antimicrobial Testing, 18th Informational Supplement, 28, 123. Wayne, PA: Clinical and Laboratory Standards Institute.
  8. Department of Health ( 2010; ). Introduction of Prevenar 13 TM into the Childhood Immunisation Programme. Letter from Professor David Salisbury, Director of Immunisation, DH, 8 February 2010 (Gateway Reference 13581).
  9. Enright, M. C. & Spratt, B. G. ( 1998; ). A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 144, 3049–3060.[CrossRef]
    [Google Scholar]
  10. Hansman, D. & Bullen, M. M. ( 1967; ). A resistant pneumococcus. Lancet 290, 264–265.
    [Google Scholar]
  11. Health Protection Scotland ( 2010; ). Scottish Antimicrobial Prescribing Group (SAPG). Report on Antimicrobial Resistance and Use in Humans in 2008. Health Protection Scotland and Information Services Division. http://www.documents.hps.scot.nhs.uk/hai/amr/annual-report/2008-sapg-amr-report.pdf.
  12. Hieber, J. P. & Nelson, J. D. ( 1977; ). A pharmacologic evaluation of penicillin in children with purulent meningitis. N Engl J Med 297, 410–413.[CrossRef]
    [Google Scholar]
  13. Jacobs, M. R., Felmingham, D., Appelbaum, P. C. & Grüneberg, R. N., Alexander Project Group ( 2003; ). The Alexander Project 1998–2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother 52, 229–246.[CrossRef]
    [Google Scholar]
  14. Jefferies, J., Clarke, S. C., Diggle, M. A., Smith, A., Dowson, C. & Mitchell, T. ( 2003; ). Automated pneumococcal MLST using liquid-handling robotics and a capillary DNA sequencer. Mol Biotechnol 24, 303–307.[CrossRef]
    [Google Scholar]
  15. Jefferies, J. M. C., Smith, A., Clarke, S. C., Dowson, C. & Mitchell, T. J. ( 2004; ). Genetic analysis of diverse disease-causing pneumococci indicates high levels of diversity within serotypes and capsule switching. J Clin Microbiol 42, 5681–5688.[CrossRef]
    [Google Scholar]
  16. Jefferies, J. M., Smith, A. J., Edwards, G. F. S., McMenamin, J., Mitchell, T. J. & Clarke, S. C. ( 2010; ). Temporal analysis of invasive pneumococcal clones from Scotland illustrates fluctuations in diversity of serotype and genotype in the absence of pneumococcal conjugate vaccine. J Clin Microbiol 48, 87–96.[CrossRef]
    [Google Scholar]
  17. Kyaw, M. H., Clarke, S., Edwards, G. F., Jones, I. G. & Campbell, H. ( 2000; ). Serotypes/groups distribution and antimicrobial resistance of invasive pneumococcal isolates: implications for vaccine strategies. Epidemiol Infect 125, 561–572.[CrossRef]
    [Google Scholar]
  18. Lim, W. S., Baudouin, S. V., George, R. C., Hill, A. T., Jamieson, C., Le Jeune, I., Macfarlane, J. T., Read, R. C., Roberts, H. J. & other authors ( 2009; ). BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 64, iii1–iii55.
    [Google Scholar]
  19. McGee, L., McDougal, L., Zhou, J., Spratt, B. G., Tenover, F. C., George, R., Hakenbeck, R., Hryniewicz, W., Lefévre, J. C. & other authors ( 2001; ). Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network. J Clin Microbiol 39, 2565–2571.[CrossRef]
    [Google Scholar]
  20. Musher, D. M., Bartlett, J. G. & Doern, G. V. ( 2001; ). A fresh look at the definition of susceptibility of Streptococcus pneumoniae to beta-lactam antibiotics. Arch Intern Med 161, 2538–2544.[CrossRef]
    [Google Scholar]
  21. Pelton, S. I., Huot, H., Finkelstein, J. A., Bishop, C. J., Hsu, K. K., Kellenberg, J., Huang, S. S., Goldstein, R. & Hanage, W. P. ( 2007; ). Emergence of 19A as virulent and multidrug resistant pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr Infect Dis J 26, 468–472.[CrossRef]
    [Google Scholar]
  22. Smart, L. E. ( 1986; ). Serotyping of Streptococcus pneumoniae strains by coagglutination. J Clin Pathol 39, 328–331.[CrossRef]
    [Google Scholar]
  23. Smith, A. J., Jefferies, J., Clarke, S. C., Dowson, C., Edwards, G. F. S. & Mitchell, T. J. ( 2006; ). Distribution of epidemic antibiotic-resistant pneumococcal clones in Scottish pneumococcal isolates analysed by multilocus sequence typing. Microbiology 152, 361–365.[CrossRef]
    [Google Scholar]
  24. Song, J. H., Jung, S. I., Ki, H. K., Shin, M. H., Ko, K. S., Son, J. S., Chang, H. H., Kim, S. W., Lee, H. & other authors ( 2004; ). Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in Asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens. Clin Infect Dis 38, 1570–1578.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.022954-0
Loading
/content/journal/jmm/10.1099/jmm.0.022954-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error